Calidi Biotherapeutics, Inc. (CLDI)
AMEX·Healthcare·Biotechnology
$1.87
+11.31%
Mkt Cap $2.62M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.50
Range $2.00 – $9.00
Implied Upside
+194.1%
Consensus $5.50 vs current $1.87
AMEX·Healthcare·Biotechnology
$1.87
+11.31%
Mkt Cap $2.62M
No recent rating data.
Price Target (2 analysts)
$5.50
Range $2.00 – $9.00
+194.1%
Consensus $5.50 vs current $1.87